Sveriges Riksbank
| Auction date | 2021-01-15 |
| Loan | 1053 |
| Coupon | 3.50 % |
| ISIN-code | SE0002829192 |
| Maturity | 2039-03-30 |
| Tendered volume, SEK mln | 1,000 +/- 500 |
| Volume offered, SEK mln | 3,500 |
| Volume bought, SEK mln | 1,000 |
| Number of bids | 16 |
| Number of accepted bids | 5 |
| Average yield | 0.314 |
| Lowest accepted yield | 0.306 |
| Highest yield | 0.318 |
| % accepted at lowest yield | 43.20 |
| Auction date | 2021-01-15 |
| Loan | 1063 |
| Coupon | 0.50 % |
| ISIN-code | SE0015193313 |
| Maturity | 2045-11-24 |
| Tendered volume, SEK mln | 500 +/- 250 |
| Volume offered, SEK mln | 1,750 |
| Volume bought, SEK mln | 500 |
| Number of bids | 20 |
| Number of accepted bids | 6 |
| Average yield | 0.472 |
| Lowest accepted yield | 0.467 |
| Highest yield | 0.476 |
| % accepted at lowest yield | 33.33 |
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Eavor Technologies Inc.17.10.2025 18:00:00 CEST | Press release
Mark Fitzgerald Appointed President and Chief Executive Officer of Eavor Technologies Inc.
Zealand Pharma17.10.2025 17:05:17 CEST | Press release
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom